SCHEMBL31712859

SCHEMBL31712859

NC(=O)c1cnc2ncc3c(c2c1)CCC3

nearest known ligand 0.48

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
NNMT P40261 6/20 0.48
CYP11B2 P19099 2/20 0.37
SMN1; SMN2 Q16637 3/20 0.34
MAPT P10636 2/20 0.34
RAB9A P51151 2/20 0.34
NPC1 O15118 3/20 0.33
AKT1 P31749 1/20 0.33
KDM4E B2RXH2 1/20 0.33
PSMD14 O00487 1/20 0.33
STAMBP O95630 1/20 0.33
COPS5 Q92905 1/20 0.33
NLRP3 Q96P20 1/20 0.32
HPGDS O60760 1/20 0.32
OPRM1 P35372 2/20 0.32
OPRD1 P41143 2/20 0.32
OPRK1 P41145 1/20 0.32
NOS3 P29474 1/20 0.32
NOS1 P29475 1/20 0.32
NOS2 P35228 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20722502 0.83 NNMT (0.43) NNMTCYP11B2SMN1; SMN2AKT1KDM4E
SCHEMBL31712856 0.81 NNMT (0.40) NNMTSMN1; SMN2PSMD14STAMBPCOPS5
SCHEMBL31712871 0.79 NNMT (0.40) NNMTCYP11B2SMN1; SMN2MAPTRAB9A
SCHEMBL26607684 0.72 NNMT (0.58) NNMTCYP11B2SMN1; SMN2MAPTRAB9A
SCHEMBL31712899 0.72 SIRT6 (0.37) NNMTCYP11B2SMN1; SMN2MAPTRAB9A
SCHEMBL17675163 0.69 NNMT (0.58) NNMTCYP11B2SMN1; SMN2MAPTRAB9A
SCHEMBL30450524 0.68 SIRT3 (0.43) NNMTCYP11B2MAPTKDM4E
SCHEMBL29106373 0.68 KDM4E (0.38) KDM4EPSMD14
SCHEMBL29056855 0.67 POLB (0.38) NNMTCYP11B2SMN1; SMN2MAPTRAB9A
SCHEMBL25275289 0.66 NNMT (0.38) NNMTHPGDS

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4251624-B1 TRICYCLIC CARBOXAMIDE DERIVATIVES AS PRMT5 INHIBITORS AMGEN INC (US) 2025-10-29 EP claimed